Viktor Horváth

465 total citations
20 papers, 433 citations indexed

About

Viktor Horváth is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Viktor Horváth has authored 20 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Viktor Horváth's work include Metal complexes synthesis and properties (6 papers), Cancer-related Molecular Pathways (6 papers) and Ferrocene Chemistry and Applications (4 papers). Viktor Horváth is often cited by papers focused on Metal complexes synthesis and properties (6 papers), Cancer-related Molecular Pathways (6 papers) and Ferrocene Chemistry and Applications (4 papers). Viktor Horváth collaborates with scholars based in Czechia, Slovakia and Sweden. Viktor Horváth's co-authors include Alois Kozubı́k, Jiřina Hofmanová, Karel Souček, Petr Sova, Peter Fedoročko, Lenka Šindlerová, Aleš Hampl, Jaromír Mikeš, Vı́tězslav Bryja and Alena Hyršlová Vaculová and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cellular and Molecular Life Sciences and Biochemical Pharmacology.

In The Last Decade

Viktor Horváth

20 papers receiving 423 citations

Peers

Countries citing papers authored by Viktor Horváth

Since Specialization

Citations

This map shows the geographic impact of Viktor Horváth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Horváth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Horváth more than expected).

Fields of papers citing papers by Viktor Horváth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Horváth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Horváth. The network helps show where Viktor Horváth may publish in the future.

Co-authorship network of co-authors of Viktor Horváth

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Horváth. A scholar is included among the top collaborators of Viktor Horváth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Horváth. Viktor Horváth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway 2010 ·Carcinogenesis ·(unknown), (unknown), Árpád Szöőr, (unknown), Karel Souček, Viktor Horváth, Alena Hyršlová Vaculová, Ladislav Anděra, Petr Sova, János Szöllõsi, Jiřina Hofmanová, György Vereb, Alois Kozubı́k	39
2	LA-12 overcomes confluence-dependent resistance of HT-29 colon cancer cells to Pt (II) compounds. 2010 ·PubMed ·Lenka Šindlerová, (unknown), Alena Hyršlová Vaculová, Viktor Horváth, Karel Souček, Petr Sova, Jiřina Hofmanová, Alois Kozubı́k	14
3	Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin 2008 ·Journal of Photochemistry and Photobiology B Biology ·(unknown), Jaromír Mikeš, Viktor Horváth, (unknown), Jiřina Hofmanová, Alois Kozubı́k, Peter Fedoročko	18
4	Lineage specific composition of cyclin D–CDK4/CDK6–p27 complexes reveals distinct functions of CDK4, CDK6 and individual D‐type cyclins in differentiating cells of embryonic origin 2008 ·Cell Proliferation ·Vı́tězslav Bryja, Jiřı́ Pachernı́k, Jan Vondráček, Karel Souček, Lukáš Čajánek, Viktor Horváth, Zuzana Holubcová, Petr Dvořák, Aleš Hampl	26
5	MECHANISMS OF EFFECTS OF PLATINUM (II) AND (IV) COMPLExES. COMPARISON OF CISPLATIN AND OxALIPLATIN wITH SATRAPLATIN AND LA-12, NEw PT(IV)-BASED DRUGS. A MINIREVIEw 2008 ·Viktor Horváth, (unknown)	7
6	Neural Differentiation Potentiated by the Leukaemia Inhibitory Factor through STAT3 Signalling in Mouse Embryonal Carcinoma Cells 2007 ·Folia Biologica ·Jiřı́ Pachernı́k, Viktor Horváth, Lukáš Kubala, Petr Dvořák, Alois Kozubı́k, Aleš Hampl	15
7	Modulation of Hypericin Photodynamic Therapy by Pretreatment with 12 Various Inhibitors of Arachidonic Acid Metabolism in Colon Adenocarcinoma HT‐29 Cells 2007 ·Photochemistry and Photobiology ·(unknown), Jaromír Mikeš, (unknown), Ján Kovaĺ, (unknown), Peter Solár, Viktor Horváth, Jiřina Hofmanová, Alois Kozubı́k, Peter Fedoročko	27
8	p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts 2007 ·Differentiation ·(unknown), Viktor Horváth, Alois Kozubı́k, Antonı́n Lojek, Joseph S. Lipsick, Jan Šmarda	3
9	Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis 2007 ·Leukemia Research ·(unknown), Karel Souček, Viktor Horváth, Jan Šmarda	14
10	Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin 2007 ·Investigational New Drugs ·Viktor Horváth, Karel Souček, Lenka Šindlerová, Jan Vondráček, (unknown), Jiřina Hofmanová, Petr Sova, Alois Kozubı́k	21
11	Effect of Adenosine on the Growth of Human T-Lymphocyte Leukemia Cell Line MOLT-4 2007 ·Cancer Investigation ·(unknown), Lenka Weiterová, Michal Hofer, (unknown), Viktor Horváth, Alois Kozubı́k, Vladimı́r Znojil	2
12	Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin 2007 ·Photochemical & Photobiological Sciences ·Jaromír Mikeš, (unknown), (unknown), Viktor Horváth, (unknown), Alena Hyršlová Vaculová, Alois Kozubı́k, Jiřina Hofmanová, Peter Fedoročko	46
13	c-Jun induces apoptosis of starved BM2 monoblasts by activating cyclin A-CDK2 2006 ·Biochemical and Biophysical Research Communications ·Petr Vaňhara, Vı́tězslav Bryja, Viktor Horváth, Alois Kozubı́k, Aleš Hampl, Jan Šmarda	3
14	Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin 2006 ·Journal of Photochemistry and Photobiology B Biology ·(unknown), (unknown), Jaromír Mikeš, Viktor Horváth, (unknown), (unknown), Jiřina Hofmanová, Alois Kozubı́k, Peter Fedoročko	21
15	Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells 2005 ·Gynecologic Oncology ·Viktor Horváth, (unknown), Lenka Šindlerová, Karel Souček, Jiřina Hofmanová, Petr Sova, (unknown), Peter Fedoročko, Alois Kozubı́k	29
16	Abnormal Development of Mouse Embryoid Bodies Lacking p27 ^Kip1 Cell Cycle Regulator 2005 ·Stem Cells ·Vı́tězslav Bryja, Lukáš Čajánek, Jiřı́ Pachernı́k, Anita Hall, Viktor Horváth, Petr Dvořák, Aleš Hampl	22
17	High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro 2004 ·Biochemical Pharmacology ·Alois Kozubı́k, Viktor Horváth, Lenka Šindlerová, Karel Souček, Jiřina Hofmanová, Petr Sova, (unknown), F. Žák, (unknown), Jaroslav Tuřánek	50
18	New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes 2004 ·Anti-Cancer Drugs ·Jaroslav Tuřánek, (unknown), (unknown), Jiřı́ Neča, (unknown), Pavlína Turánek Knötigová, Viktor Horváth, Lenka Šindlerová, Alois Kozubı́k, Petr Sova, (unknown), F. Žák, (unknown)	36
19	Increased apoptosis in differentiating p27-deficient mouse embryonic stem cells 2004 ·Cellular and Molecular Life Sciences ·Vı́tězslav Bryja, (unknown), Karel Souček, Viktor Horváth, (unknown), Aleš Hampl	27
20	Induction of cytotoxicity and ssDNA breaks by 9-bromo-5-morpholino-tetrazolo[1,5-c]quinazoline in tumor cells cultured in vitro 2003 ·Toxicology in Vitro ·Soňa Jantová, Luboš Čipák, Darina Slameňová, Viktor Horváth, P Rauko	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact